Clinical trial
Serelaxin To Lower Portal Pressure in Patients With Cirrhosis and Portal Hypertension
NCT02669875 is registered in ClinicalTrials.gov with University of Edinburgh as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Serelaxin To Lower Portal Pressure in Patients With Cirrhosis and Portal Hypertension
- Lead sponsor
- University of Edinburgh
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- October 18, 2017
- Completion date
- August 31, 2018
- Enrollment
- 15 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.